Poland· PL-100376015
Nervosol TABS
A medicinal product containing valerianae extractum hydroalcoholicum siccum + lupuli floris extractum siccum, registered in Poland by Wrocławskie Zakłady Zielarskie "Herbapol" S.A..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Valerianae extractum hydroalcoholicum siccum + Lupuli floris extractum siccum
- Manufacturer
- Wrocławskie Zakłady Zielarskie "Herbapol" S.A.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05906014013102
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e78efd24-ec5b-42a4-920e-426cc9ecd857 GET /v1/drugs/e78efd24-ec5b-42a4-920e-426cc9ecd857?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "100 mg + 32 mg",
"packaging": "05906014013102 ¦ OTC ¦ 117364\n30 tabl.",
"substance": "Valerianae extractum hydroalcoholicum siccum 100 mg + Lupuli floris extractum siccum 32 mg",
"common_name": "Valerianae extractum hydroalcoholicum siccum + Lupuli floris extractum siccum",
"pl_product_id": "100376015",
"pozwolenie_nr": "24054",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about valerianae extractum hydroalcoholicum siccum + lupuli floris extractum siccum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.